NIH-funded research NIH-funded research

Inflammation-linked autophagy problems in blood cells with sickle cell disease

Official title: Inflammation-associated Autophagy Dysfunction

Funded at Seattle Children's Hospital · NIH-11539153 · Data updated 2026-11-12

A scientist is studying how inflammation from TNF-alpha affects autophagy in platelets and red blood cells of people with sickle cell disease to better understand why blood clotting and cell health go awry.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 17, 2026
Project endMay 31, 2028
Funding year2026
Award (this year)$469,250
NIH project number7R00HL177831-02
Project IDNIH-11539153 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with sickle cell disease or related blood disorders who could contribute blood-derived samples for analysis.

Less likely to help

People without sickle cell disease or related hematologic conditions are unlikely to directly benefit.

What this research studies

This project focuses on how TNF-alpha-driven inflammation may block autophagy and mitophagy in platelets and reticulocytes from people with sickle cell disease, potentially causing dysfunctional mitochondria and abnormal blood clotting. The work will examine shared pathways in cells that come from the same blood-forming progenitors to see how inflammation alters their mitochondrial clearance. Researchers will use human-derived samples and laboratory models to explore the mechanisms behind impaired mitochondrial removal and its effects on hemostasis. The findings could reveal targets to restore proper autophagy and improve blood health in SCD.

Why it matters

Potential benefit: If successful, the work could point to new ways to reduce blood cell dysfunction and abnormal clotting in sickle cell disease.

How similar studies have gone: Prior studies have linked inflammation and mitochondrial dysfunction to blood cell abnormalities; this project builds on those ideas in a unique SCD context.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Davizon-Castillo, Pavel — Seattle Children's Hospital
  • Study coordinator: Davizon-Castillo, Pavel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.